Dishman Carbogen Amcis
Dishman Carbogen Amcis, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in India. Founded in 1983, the company has established itself as a leader in contract research and manufacturing services, with a strong presence in Europe, North America, and Asia. Specialising in custom synthesis, active pharmaceutical ingredients (APIs), and drug development services, Dishman Carbogen Amcis is recognised for its innovative approach and commitment to quality. The company’s state-of-the-art facilities and expertise in complex chemistry set it apart in a competitive market. With a focus on sustainability and regulatory compliance, Dishman Carbogen Amcis has achieved significant milestones, including successful collaborations with major pharmaceutical companies. Its dedication to excellence has solidified its position as a trusted partner in the global pharmaceutical landscape.
DitchCarbon Score
How does Dishman Carbogen Amcis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dishman Carbogen Amcis's score of 4 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Dishman Carbogen Amcis's reported carbon emissions
In 2023, Dishman Carbogen Amcis reported total carbon emissions of approximately 68,113,600 kg CO2e from Scope 1 and 15,700,600 kg CO2e from Scope 2. This represents a slight increase in Scope 1 emissions compared to 2022, where they recorded about 48,975,800 kg CO2e for Scope 1 and 17,489,600 kg CO2e for Scope 2. For 2024, the company anticipates emissions of about 58,157,000 kg CO2e from Scope 1 and 17,725,920 kg CO2e from Scope 2. Dishman Carbogen Amcis has not publicly disclosed specific reduction targets or initiatives as part of their climate commitments. However, they continue to monitor and report their emissions, indicating a commitment to transparency in their environmental impact. The company’s emissions intensity metrics, such as 62.0 kg CO2e per tonne of physical output in 2023, provide insight into their operational efficiency relative to their carbon footprint. Overall, while specific reduction strategies are not outlined, the ongoing emissions reporting reflects an awareness of climate impact and a potential pathway for future commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 48,975,800 | 00,000,000 | 00,000,000 |
| Scope 2 | 17,489,600 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dishman Carbogen Amcis is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
